Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Estriol
Aspen Pharma Trading Limited
G03CA; G03CA04
Estriol
1 milligram(s)
Vaginal cream
Product subject to prescription which may be renewed (B)
Natural and semisynthetic estrogens, plain; estriol
Not marketed
1993-08-16
PACKAGE LEAFLET: INFORMATION FOR THE USER OVESTIN 1MG PER GRAM, VAGINAL CREAM Estriol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have further questions, please ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Ovestin is and what it is used for 2. What you need to know before you use Ovestin 3. How to use Ovestin 4. Possible side effects 5. How to store Ovestin 6. Contents of the pack and other Information 1. WHAT OVESTIN IS AND WHAT IT IS USED FOR Ovestin belongs to a group of medicines called vaginal Hormone Replacement Therapy (HRT). It contains the female hormone estriol (an estrogen). Ovestin is used in postmenopausal women with at least 12 months since their last period. It is used to relieve menopausal symptoms in the vagina such as dryness or irritation. In medical terms this is known as ‘vaginal atrophy’. It is caused by a drop in the levels of oestrogen in your body. This happens naturally after the menopause. The active substance of Ovestin is estriol, one of the natural estrogens produced by the body (female sex hormones). Estrogens are mainly produced in the ovaries. They are necessary for the normal sexual development of women and for the regulation of the menstrual cycle during the childbearing years. When women get older the ovaries gradually produce less estrogen. The period in which this happens (usually around the age of 50) is called the menopause. If the ovaries are removed surgically (ovariectomy) before the menopause, the decrease in estrogen production occurs very abruptly. The shortage of estrogens during menopause may cause the vaginal w Прочитајте комплетан документ
Health Products Regulatory Authority 20 November 2023 CRN00DXV6 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ovestin 1mg per gram Vaginal Cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Vaginal cream containing 1 mg estriol in 1 g of cream. Excipient(s) with known effect: Cetyl alcohol 36.7 mg per 1 g cream and stearyl alcohol 88.4 mg per 1g cream For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Vaginal cream with applicator. Ovestin cream is a homogeneous, smooth, white to nearly white mass of creamy consistency. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TREATMENT OF VAGINAL OESTROGEN DEFICIENCY SYMPTOMS: Treatment of symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women. Pre and post operative therapy in post-menopausal women undergoing vaginal surgery. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For atrophy of the lower urogenital tract: 1 application per day for the first weeks (maximally 4 weeks), followed by a gradual reduction, based on relief of symptoms, until a maintenance dosage (e.g. 1 application twice a week) is reached. As pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery: 1 application per day in the 2 weeks before surgery: 1 application twice a week in the 2 weeks after surgery. A missed dose should be administered as soon as remembered, unless the missed dose is noticed at the day of the next dose. In the latter case the missed dose should be skipped and the regular dosing scheme continued. Two doses must never be administered on the same day. Method of administration Ovestin Cream should be administered intravaginally by means of a calibrated applicator before retiring at night. 1 applicator-dose (applicator filled to the ring mark) contains 0.5 g Ovestin Cream which corresponds to 0.5 mg estriol. The following 'Instructions for Use' should be given to the patient and are included in the package leaflet: INSTRUCTIONS FOR USE 1. Remove the cap from the tube, Прочитајте комплетан документ